Recombinant Proteins
Modified or manipulated proteins encoded by recombinant DNA and suitable for a variety of purposes including the modification of gene sequences, mass protein production, and the manufacture of commercial products.
brands:
Pepro Tech Inc
Clear all selections
Filtered Search Results
Products from some of our suppliers do not display in filtered search results. Please
clear all filters
to see these products.
Search Within Results
Keyword Search:
Clear All
1
–
15
of
19
results
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | G-CSF |
| Molecular Weight (g/mol) | 18.7 kDa |
| Gene Symbol | Csf3 |
| Activity | Determined by its ability to stimulate the proliferation of mouse NFS-60 cells. The expected ED50 is ≤ 0.1 ng/ml, corresponding to a specific activity of ≥ 1 x 10^7 units/mg |
| Endotoxin Concentration | <0.1 EU/ μg |
| Sequence | TPLGPASSLP QSFLLKCLEQ VRKIQGDGAA LQEKLCATYK LCHPEELVLL GHSLGIPWAP LSSCPSQALQ LAGCLSQLHS GLFLYQGLLQ ALEGISPELG PTLDTLQLDV ADFATTIWQQ MEELGMAPAL QPTQGAMPAF ASAFQRRAGG VLVASHLQSF LEVSYRVLRH LAQP |
| Expression System | E. coli |
| For Use With (Application) | ELISA,Functional Assay,Western Blot |
| Name | Human G-CSF, Animal-Free |
| Accession Number | P09919 |
| Purification Method | HPLC, SDS-PAGE |
| Gene Alias | C17orf33; colony stimulating factor 3; colony stimulating factor 3 (granulocyte); CSF 3; CSF3; CSF3OS; Csfg; filgrastim; GCSF; G-CSF; Granulocyte colony-stimulating factor; granulocyte-colony stimulating factor; gsf3; lenograstim; MGC45931; MGI-IG; Pluripoietin; RP23-395E10.4 |
| Format | Lyophilized |
| Product Type | Protein |
| Biological Activity | Determined by its ability to stimulate the proliferation of mouse NFS-60 cells. The expected ED50 is ≤ 0.1 ng/ml, corresponding to a specific activity of ≥ 1 x 10^7 units/mg |
| Gene ID (Entrez) | 1440 |
| Formulation | protein with no preservative |
| Recombinant | Recombinant |
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 95% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | IL1F9 |
| Molecular Weight (g/mol) | 17 kDa |
| Gene Symbol | IL36G |
| Activity | Measured by its ability to induce IL-8 production by human PBMCs. |
| Endotoxin Concentration | <0.1 EU/ μg |
| Sequence | SMCKPITGTI NDLNQQVWTL QGQNLVAVPR SDSVTPVTVA VITCKYPEAL EQGRGDPIYL GIQNPEMCLY CEKVGEQPTL QLKEQKIMDL YGQPEPVKPF LFYRAKTGRT STLESVAFPD WFIASSKRDQ PIILTSELGK SYNTAFELNI ND |
| Expression System | E. coli |
| For Use With (Application) | ELISA,Functional Assay,Western Blot |
| Name | Human IL-36 gamma (IL-1F9), Animal-Free |
| Accession Number | Q9NZH8 |
| Purification Method | HPLC, SDS-PAGE |
| Gene Alias | IL-1 epsilon; IL-1 related protein 2; IL-1(EPSILON); IL1E; IL-1-epsilon; IL1F9; IL-1F9; IL1H1; IL-1H1; IL-1-related protein 2; IL1RP2; IL-1 RP2; IL36G; Interleukin; interleukin 1 family, member 9; interleukin 1-related protein 2; interleukin 36, gamma; interleukin-1 epsilon; Interleukin-1 family member 9; interleukin-1 homolog 1; Interleukin-36; Interleukin-36 gamma; UNQ2456/PRO5737 |
| Format | Lyophilized |
| Product Type | Protein |
| Biological Activity | Measured by its ability to induce IL-8 production by human PBMCs. |
| Gene ID (Entrez) | 56300 |
| Formulation | protein with no preservative |
| Recombinant | Recombinant |
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | IL-16 |
| Molecular Weight (g/mol) | 12.4 kDa |
| Gene Symbol | IL16 |
| Activity | Determined by its ability to chemoattract human peripheral blood lymphocytes using a concentration range of 50.0-1000.0 ng/ml |
| Endotoxin Concentration | <0.1 EU/ μg |
| Sequence | SAASASAASD VSVESTAEAT VCTVTLEKMS AGLGFSLEGG KGSLHGDKPL TINRIFKGAA SEQSETVQPG DEILQLGGTA MQGLTRFEAW NIIKALPDGP VTIVIRRKSL QSKETTAAGD S |
| Expression System | E. coli |
| For Use With (Application) | Functional Assay |
| Name | Human IL-16 (121 aa), Animal-Free |
| Accession Number | Q14005 |
| Purification Method | HPLC, SDS-PAGE |
| Gene Alias | FLJ16806; FLJ42735; FLJ44234; H-IL-16; il 16; Il16; IL-16; ILN; Interleukin; interleukin 16; Interleukin16; Interleukin-16; LCF; Lymphocyte chemoattractant factor; M-IL-16; mKIAA4048; neuronal interleukin 16; NIL16; PRIL16; prIL-16; prointerleukin 16; Pro-interleukin-16 |
| Format | Lyophilized |
| Product Type | Protein |
| Biological Activity | Determined by its ability to chemoattract human peripheral blood lymphocytes using a concentration range of 50.0-1000.0 ng/ml |
| Gene ID (Entrez) | 3603 |
| Formulation | protein with no preservative |
| Recombinant | Recombinant |
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
|---|---|
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Molecular Weight (g/mol) | 6.2 kDa |
| Formulation | protein with no preservative |
| Endotoxin Concentration | <0.1 EU/ μg |
| Sequence | MNSNTGCPPS YDGYCLNGGV CMYVESVDRY VCNCVIGYIG ERCQHRDLRW WKLR |
| For Use With (Application) | Functional Assay |
| Name | Rat EGF, Animal-Free |
| Recombinant | Recombinant |
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | IL-25 |
| Molecular Weight (g/mol) | 33.8 kDa |
| Gene Symbol | IL25 |
| Activity | Determined by its ability to induce IL-8 in. human PBMCs using a concentration range of 10-100 ng. |
| Endotoxin Concentration | <0.1 EU/ μg |
| Sequence | MYSHWPSCCP SKGQDTSEEL LRWSTVPVPP LEPARPNRHP ESCRASEDGP LNSRAISPWR YELDRDLNRL PQDLYHARCL CPHCVSLQTG SHMDPRGNSE LLYHNQTVFY RRPCHGEKGT HKGYCLERRL YRVSLACVCV RPRVMG |
| Expression System | E. coli |
| For Use With (Application) | Functional Assay |
| Name | Human IL-17 E (IL-25), Animal-Free |
| Accession Number | Q9H293 |
| Purification Method | HPLC, SDS-PAGE |
| Gene Alias | D17Wsu104e; il 17 e; Il17e; IL-17 E; Il25; IL-25; ILN; Interleukin; interleukin 17 E; interleukin 25; interleukin-17 E; Interleukin-25; Ly6elg; Mydgf; myeloid derived growth factor; myeloid-derived growth factor; RGD1561632; UNQ3120/PRO10272; UPF0556 protein C19orf10 homolog |
| Format | Lyophilized |
| Product Type | Protein |
| Biological Activity | Determined by its ability to induce IL-8 in. human PBMCs using a concentration range of 10-100 ng. |
| Gene ID (Entrez) | 64806 |
| Formulation | protein with no preservative |
| Recombinant | Recombinant |
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | IL-29 |
| Molecular Weight (g/mol) | 19.8 kDa |
| Gene Symbol | IFNL1 |
| Activity | Determined by its ability to activate STAT phosphorylation in an ISRE Luciferase Reporter Assay using human colon carcinoma COLO205 cells. The expected ED50 is 0.2-0.5 ng/ml |
| Endotoxin Concentration | <0.1 EU/ μg |
| Sequence | PTSKPTTTGK GCHIGRFKSL SPQELASFKK ARDALEESLK LKNWSCSSPV FPGNWDLRLL QVRERPVALE AELALTLKVL EAAAGPALED VLDQPLHTLH HILSQLQACI QPQPTAGPRP RGRLHHWLHR LQEAPKKESA GCLEASVTFN LFRLLTRDLK YVADGNLCLR TSTHPEST |
| Expression System | E. coli |
| For Use With (Application) | Functional Assay |
| Name | Human IL-29 (IFN lambda-1), Animal-Free |
| Accession Number | Q8IU54 |
| Purification Method | HPLC, SDS-PAGE |
| Gene Alias | cytokine Zcyto21; Cytokine Zcyto22; FNL1; IFN lambda1; IFNL1; IFNL3; IFN-lambda-1; IFN-lambda-3; IFN-lambda-4; IL28B; IL-28 B; IL28C; IL-28 C; IL29; IL-29; ILN; interferon lambda 1; interferon lambda 3; Interferon lambda1; interferon lambda-1; Interferon lambda-3; interferon, lambda 1; interferon, lambda 3; interferon, lambda 4; interferon-lambda-1; Interleukin; interleukin 29 (interferon, lambda 1); interleukin-28 B; Interleukin-28 C; interleukin-29; ZCYTO21; ZCYTO22 |
| Format | Lyophilized |
| Product Type | Protein |
| Biological Activity | Determined by its ability to activate STAT phosphorylation in an ISRE Luciferase Reporter Assay using human colon carcinoma COLO205 cells. The expected ED50 is 0.2-0.5 ng/ml |
| Gene ID (Entrez) | 282618 |
| Formulation | protein with no preservative |
| Recombinant | Recombinant |
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | VEGF-165 |
| Molecular Weight (g/mol) | 39 kDa |
| Gene Symbol | Vegfa |
| Activity | Determined by the dose-dependent stimulation of the proliferation of human umbilical vein endothelial cells (HUVEC) using a concentration range of 1.0-5.0 ng/ml |
| Endotoxin Concentration | <0.1 EU/ μg |
| Sequence | MAPTTEGEQK SHEVIKFMDV YQRSYCRPIE TLVDIFQEYP DEIEYIFKPS CVPLMRCAGC CNDEALECVP TSESNITMQI MRIKPHQSQH IGEMSFLQHS RCECRPKKDR TKPEKHCEPC SERRKHLFVQ DPQTCKCSCK NTDSRCKARQ LELNERTCRC DKPRR |
| Expression System | E. coli |
| For Use With (Application) | Functional Assay |
| Name | Mouse VEGF-165, Animal-Free |
| Accession Number | Q00731 |
| Purification Method | HPLC, SDS-PAGE |
| Gene Alias | H-VEGF-165; MVCD1; M-VEGF-165; vascular endothelial growth factor 165 b; vascular endothelial growth factor A; vascular endothelial growth factor A121; vascular endothelial growth factor A165; vascular permeability factor; VEGF; VEGF164; VEGF165; Vegfa; VEGF-A; VPF |
| Format | Lyophilized |
| Product Type | Protein |
| Biological Activity | Determined by the dose-dependent stimulation of the proliferation of human umbilical vein endothelial cells (HUVEC) using a concentration range of 1.0-5.0 ng/ml |
| Gene ID (Entrez) | 22339 |
| Formulation | protein with no preservative |
| Recombinant | Recombinant |
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
|---|---|
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Molecular Weight (g/mol) | 16.3 kDa |
| Formulation | protein with no preservative |
| Endotoxin Concentration | <0.1 EU/ μg |
| Sequence | MQKGDQNPQI AAHVISEASS KTTSVLQWAE KGYYTMSNNL VTLENGKQLT VKRQGLYYIY AQVTFCSNRE ASSQAPFIAS LWLKSPGRFE RILLRAANTH SSAKPCGQQS IHLGGVFELQ PGASVFVNVT DPSQVSHGTG FTSFGLLKL |
| For Use With (Application) | Functional Assay |
| Name | Human CD40 Ligand (TNFSF5) (soluble), Animal-Free |
| Recombinant | Recombinant |
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | IL-9 |
| Molecular Weight (g/mol) | 14 kDa |
| Gene Symbol | Il9 |
| Activity | Determined by its ability to stimulate the proliferation of human MO7e cells. The expected ED50 is ≤ 0.2 ng/ml, corresponding to a specific activity of ≥ 5 x 10^6 units/mg |
| Endotoxin Concentration | <0.1 EU/ μg |
| Sequence | MQGCPTLAGI LDINFLINKM QEDPASKCHC SANVTSCLCL GIPSDNCTRP CFSERLSQMT NTTMQTRYPL IFSRVKKSVE VLKNNKCPYF SCEQPCNQTT AGNALTFLKS LLEIFQKEKM RGMRGKI |
| Expression System | E. coli |
| For Use With (Application) | Functional Assay |
| Name | Human IL-9, Animal-Free |
| Accession Number | P15248 |
| Purification Method | HPLC, SDS-PAGE |
| Gene Alias | cytokine P40; homolog of mouse T cell and mast cell growth factor 40; HP40; IL9; IL-9; ILN; Interleukin; interleukin 9; Interleukin9; interleukin-9; P40; p40 cytokine; p40 T-cell and mast cell growth factor; T-cell growth factor P40 |
| Format | Lyophilized |
| Product Type | Protein |
| Biological Activity | Determined by its ability to stimulate the proliferation of human MO7e cells. The expected ED50 is ≤ 0.2 ng/ml, corresponding to a specific activity of ≥ 5 x 10^6 units/mg |
| Gene ID (Entrez) | 3578 |
| Formulation | protein with no preservative |
| Recombinant | Recombinant |
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | IL-21 |
| Molecular Weight (g/mol) | 15 kDa |
| Gene Symbol | IL21 |
| Activity | Determined by its ability to stimulate the proliferation of human ANBL-6 cells. The expected ED50 is ≤ 1.0 ng/ml, corresponding to a specific activity of ≥ 1 x 10^6 units/mg |
| Endotoxin Concentration | <0.1 EU/ μg |
| Sequence | MHKSSPQGPD RLLIRLRHLI DIVEQLKIYE NDLDPELLSA PQDVKGHCEH AAFACFQKAK LKPSNPGNNK TFIIDLVAQL RRRLPARRGG KKQKHIAKCP SCDSYEKRTP KEFLERLKWL LQKMIHQHLS |
| Expression System | E. coli |
| For Use With (Application) | Functional Assay |
| Name | Mouse IL-21, Animal-Free |
| Accession Number | Q9ES17 |
| Purification Method | HPLC, SDS-PAGE |
| Gene Alias | CVID11; C x 2; il 21; IL21; IL-21; ILN; Interleukin; interleukin 21; Interleukin21; interleukin-21; interleukin-21 isoform; porcine interleukin-21; Za11 |
| Format | Lyophilized |
| Product Type | Protein |
| Biological Activity | Determined by its ability to stimulate the proliferation of human ANBL-6 cells. The expected ED50 is ≤ 1.0 ng/ml, corresponding to a specific activity of ≥ 1 x 10^6 units/mg |
| Gene ID (Entrez) | 60505 |
| Formulation | protein with no preservative |
| Recombinant | Recombinant |
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | IL-8 |
| Molecular Weight (g/mol) | 8.4 kDa |
| Gene Symbol | CXCL8 |
| Activity | Determined by its ability to chemoattract human peripheral blood neutrophils using a concentration range of 10.0-100.0 ng/ml |
| Endotoxin Concentration | <0.1 EU/ μg |
| Sequence | SAKELRCQCI KTYSKPFHPK FIKELRVIES GPHCANTEII VKLSDGRELC LDPKENWVQR VVEKFLKRAE NS |
| Expression System | E. coli |
| For Use With (Application) | Functional Assay |
| Name | Human IL-8 (CXCL8) (72 aa), Animal-Free |
| Accession Number | P10145 |
| Purification Method | HPLC, SDS-PAGE |
| Gene Alias | (Ala-IL-8)77; (Ser-IL-8)72; Alveolar macrophage chemotactic factor I; alveolar macrophage-derived chemotactic factor-I; AMCF-I; AN x 7; beta endothelial cell-derived neutrophil activating peptide; beta-thromboglobulin-like protein; chemokine (C-X-C motif) ligand 8; C-X-C motif chemokine 8; C-X-C motif chemokine ligand 8; CXCL8; cytokine 8; emoctakin; GCP/IL-8 protein I; GCP/IL-8 protein II; GCP/IL-8 protein III; GCP/IL-8 protein IV; GCP/IL-8 protein V; GCP/IL-8 protein VI; GCP1; GCP-1; Granulocyte chemotactic protein 1; IL8; IL-8; IL-8(1-77); IL-8(5-77); IL-8(6-77); IL-8(7-77); IL-8(8-77); IL-8(9-77); IL8/NAP1 form I; IL8/NAP1 form II; IL8/NAP1 form III; IL8/NAP1 form IV; IL8/NAP1 form V; IL8/NAP1 form VI; ILN; Interleukin; interleukin 8; Interleukin8; interleukin-8; interleuklin-8 precursor; LECT; LUCT; lung giant cell carcinoma-derived chemotactic protein; lymphocyte derived neutrophil activating peptide; Lymphocyte-derived neutrophil-activating factor; LYNAP; MDNCF; MDNCF-a; MDNCF-b; MDNCF-c; MONAP; Monocyte-derived neutrophil chemotactic factor; monocyte-derived neutrophil-activating peptide; NAF; NAP1; NAP-1; neutrophil activating peptide 1; neutrophil and T-lymphocyte chemotactic and activating factor; Neutrophil attractant/activation protein 1; neutrophil attractant/activation protein-1; Neutrophil-activating factor; neutrophil-activating peptide 1; Neutrophil-activating protein 1; Permeability factor 1; PF1; Protein 3-10 C; RP11-537A6.8; RPF1; small inducible cytokine subfamily B, member 8; SNX; SYNEXIN; T-cell chemotactic factor; tumor necrosis factor-induced gene 1 |
| Format | Lyophilized |
| Product Type | Protein |
| Biological Activity | Determined by its ability to chemoattract human peripheral blood neutrophils using a concentration range of 10.0-100.0 ng/ml |
| Gene ID (Entrez) | 3576 |
| Formulation | protein with no preservative |
| Recombinant | Recombinant |
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | IL-1 alpha |
| Molecular Weight (g/mol) | 18 kDa |
| Gene Symbol | Il1a |
| Activity | Determined by its ability to stimulate the proliferation of mouse D10S cells. The expected ED50 is ≤0.001 ng/ml, corresponding to a specific activity of ≥1 x 10^9 units/mg |
| Endotoxin Concentration | <0.1 EU/ μg |
| Sequence | SAPFSFLSNV KYNFMRIIKY EFILNDALNQ SIIRANDQYL TAAALHNLDE AVKFDMGAYK SSKDDAKITV ILRISKTQLY VTAQDEDQPV LLKEMPEIPK TITGSETNLL FFWETHGTKN YFTSVAHPNL FIATKQDYWV CLAGGPPSIT DFQILENQA |
| Expression System | E. coli |
| For Use With (Application) | Functional Assay |
| Name | Human IL-1 alpha, Animal-Free |
| Accession Number | P01583 |
| Purification Method | HPLC, SDS-PAGE |
| Gene Alias | CTLA8; hematopoietin-1; IL 1 A; IL 1 A; IL1; IL-1 alpha; IL17; IL1A; Il-1 A; IL-1 alpha; IL1-ALPHA; IL1F1; IL1a; ILN; Interleukin; interleukin 1 alpha; interleukin 1, alpha; interleukin 17; interleukin 1 A; interleukin 1-alpha; interleukin 1-alpha (AA 1 - 152); Interleukin1 alpha; interleukin-1 alpha; interleukin-1 alpha precursor; Interleukin-17 A; preinterleukin 1 alpha; pre-interleukin-1 alpha; pro-interleukin-1-alpha; RP23-160G19.8 |
| Format | Lyophilized |
| Product Type | Protein |
| Biological Activity | Determined by its ability to stimulate the proliferation of mouse D10S cells. The expected ED50 is ≤0.001 ng/ml, corresponding to a specific activity of ≥1 x 10^9 units/mg |
| Gene ID (Entrez) | 3552 |
| Formulation | protein with no preservative |
| Recombinant | Recombinant |
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | CNTF |
| Molecular Weight (g/mol) | 22.7 kDa |
| Gene Symbol | CNTF |
| Activity | Determined by its ability to stimulate proliferation of human TF-1 cells using a concentration range of 25.0-35.0 ng/ml |
| Endotoxin Concentration | <0.1 EU/ μg |
| Sequence | AFAEQTPLTL HRRDLCSRSI WLARKIRSDL TALMESYVKH QGLNKNINLD SVDGVPVAST DRWSEMTEAE RLQENLQAYR TFQGMLTKLL EDQRVHFTPT EGDFHQAIHT LMLQVSAFAY QLEELMVLLE QKIPENEADG MPATVGDGGL FEKKLWGLKV LQELSQWTVR SIHDLRVISS HQMGISALES HYGAKDKQM |
| Expression System | E. coli |
| For Use With (Application) | Functional Assay |
| Name | Rat CNTF, Animal-Free |
| Accession Number | P20294 |
| Purification Method | HPLC, SDS-PAGE |
| Gene Alias | AI429687; Ciliary neurotrophic factor; ciliary neurotropic factor; Cntf; HCNTF; H-CNTF |
| Format | Lyophilized |
| Product Type | Protein |
| Biological Activity | Determined by its ability to stimulate proliferation of human TF-1 cells using a concentration range of 25.0-35.0 ng/ml |
| Gene ID (Entrez) | 25707 |
| Formulation | protein with no preservative |
| Recombinant | Recombinant |
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
|---|---|
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Molecular Weight (g/mol) | 17.2 kDa |
| Formulation | protein with no preservative |
| Endotoxin Concentration | <0.1 EU/ μg |
| Sequence | MRPSGRKSSK MQAFRIWDVN QKTFYLRNNQ LVAGYLQGPN VNLEEKIDVV PIEPHALFLG IHGGKMCLSC VKSGDETRLQ LEAVNITDLS ENRKQDKRFA FIRSDSGPTT SFESAACPGW FLCTAMEADQ PVSLTNMPDE GVMVTKFYFQ EDE |
| For Use With (Application) | Functional Assay |
| Name | Human IL-1 RA, Animal-Free |
| Recombinant | Recombinant |
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 95% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | BAFF (BLyS) |
| Molecular Weight (g/mol) | 17 kDa |
| Gene Symbol | TNFSF13B |
| Activity | Determined by a mouse splenocyte survival assay. The expected ED50 for this effect is 0.5-2.0 ug/ml |
| Endotoxin Concentration | <0.1 EU/ μg |
| Sequence | AVQGPEETVT QDCLQLIADS ETPTIQKGSY TFVPWLLSFK RGSALEEKEN KILVKETGYF FIYGQVLYTD KTYAMGHLIQ RKKVHVFGDE LSLVTLFRCI QNMPETLPNN SCYSAGIAKL EEGDELQLAI PRENAQISLD GDVTFFGALK LL |
| Expression System | E. coli |
| For Use With (Application) | Functional Assay |
| Name | Human BAFF (BLyS), Animal-Free |
| Accession Number | Q9Y275 |
| Purification Method | HPLC, SDS-PAGE |
| Gene Alias | ApoL related ligand TALL-1; b cell-activating factor; B lymphocyte stimulator; BAFF; B-cell-activating factor; B-lymphocyte stimulator; BLYS; CD257; D8Ertd387e; delta BAFF; Delta4 BAFF; dendritic cell-derived TNF-like molecule; DTL; RGD1561519; TALL1; TALL-1; THANK; TNF- and APOL-related leukocyte expressed ligand 1; TNF and ApoL-related leukocyte expressed ligand 1; TNF homolog that activates apoptosis; Tnfsf13b; TNFSF20; TNLG7A; tumor necrosis factor (ligand) superfamily member 13 b; tumor necrosis factor (ligand) superfamily, member 13 b; tumor necrosis factor (ligand) superfamily, member 20; tumor necrosis factor ligand 7 A; tumor necrosis factor ligand superfamily member 13 B; Tumor necrosis factor ligand superfamily member 13 b, membrane form; Tumor necrosis factor ligand superfamily member 13 b, soluble form; tumor necrosis factor superfamily member 13 b; tumor necrosis factor-like protein ZTNF4; UNQ401/PRO738; ZTNF4 |
| Format | Lyophilized |
| Product Type | Protein |
| Biological Activity | Determined by a mouse splenocyte survival assay. The expected ED50 for this effect is 0.5-2.0 ug/ml |
| Gene ID (Entrez) | 10673 |
| Formulation | protein with no preservative |
| Recombinant | Recombinant |